Dual-strain probiotics reduce NEC, mortality and neonatal bloodstream infections among extremely low birthweight infants

Berrington and Ward Platt recently summarised current advances in the management of preterm infants born <1000 g, so-called extremely low birthweight (ELBW) infants.1 In this thoroughly done review, the authors highlighted the findings of the 2014 Cochrane review showing probiotics to reduce all-cause mortality and necrotizing enterocolitis (NEC) in preterm infants, but not in the subgroup of ELBW infants.2 …